Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO10671 | Zephyranthes candida | Species | Amaryllidaceae | Eukaryota | Whole Plants |
PMID[23190013] |
||
NPO13120 | Pancratium maritimum | Species | Amaryllidaceae | Eukaryota | Turkey |
PMID[19299148] |
||
NPO25694 | Leucojum aestivum | Species | Amaryllidaceae | Eukaryota | Turkey |
PMID[19299148] |
||
NPO17954 | Narcissus tazetta | Species | Amaryllidaceae | Eukaryota | Turkey |
PMID[19299148] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 20090.93 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 19453.6 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 28575.91 | nM | 1965654 | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 52480.75 | nM | 15921415 | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.7 | ug/ml | 3560159 |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 27925.44 | nM | 21868221 | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 10 | 23073993 | ||
NPT111 | Cell Line | K562 | Homo sapiens | Ratio IC50 | = | 10 | 10.1016/j.cropro.2010.06.006 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 9057.33 | nM | 25237727 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 15595.53 | nM | 18672931 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 3854.78 | nM | 12502321 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 5942.92 | nM | 19097894 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 6223 | nM | 12699389 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 18923.44 | nM | DrugMatrix in vitro pharmacology data | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 23988.33 | nM | 22516426 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 14256.08 | nM | DrugMatrix in vivo data: Pathology | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 29716.66 | nM | 24224794 | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 16519.62 | nM | DrugMatrix in vitro pharmacology data | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 13963.68 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 23120.65 | nM | 24025124 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 11694.99 | nM | 16621550 | |
NPT2 | Others | Unspecified | IC50 | = | 5000 | nM | 11421752 | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 13614.45 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 15739.83 | nM | 10.6019/CHEMBL1201861 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 9162.2 | nM | 23631483 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 18749.95 | nM | 26351041 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 6382.63 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 17418.07 | nM | 18494522 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 4800 | nM | 17341062 |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 19054.61 | nM | 23145884 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 14996.85 | nM | 21216145 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 10000 | nM | 406395 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 5128.61 | nM | 6481361 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 13520.73 | nM | 16643029 | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 16557.7 | nM | 24754786 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 15488.17 | nM | 12086488 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | Ratio IC50 | = | 10 | 19124664 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 14621.77 | nM | 20719504 | |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 2500 | nM | 16643031 |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 8336.81 | nM | 10924160 | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 25409.73 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 38018.94 | nM | 12088425 | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 15275.66 | nM | 19754130 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Ratio IC50 | = | 10 | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 33342.64 | nM | 17595133 | |
NPT81 | Cell Line | A549 | Homo sapiens | Ratio IC50 | = | 10 | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 7673.61 | nM | 12713414 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 29580.12 | nM | 24697496 | |
NPT111 | Cell Line | K562 | Homo sapiens | IC50 | = | 2500 | nM | 14980653 |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 41879.36 | nM | 16434194 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 12050.36 | nM | 18345611 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 2100 | nM | 18494463 |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 6471.43 | nM | 18550377 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 18238.96 | nM | 20462236 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 30831.88 | nM | 23398362 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 1400 | nM | 10780915 |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 22646.44 | nM | 21856049 | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 16672.47 | nM | 7473578 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 10423.17 | nM | 19371071 | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 46558.61 | nM | 20350950 | |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | 21827.3 | nM | 2045816 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 23550.49 | nM | 17190440 | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 16143.59 | nM | 16643028 | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 79615.94 | nM | PubChem BioAssay data set | |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | IC50 | = | 452000 | nM | 19654408 |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 12882.5 | nM | 19786608 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 14996.85 | nM | 25462220 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC266176 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC158148 |
1.0 | High Similarity | NPC82533 |
1.0 | High Similarity | NPC290759 |
0.9873 | High Similarity | NPC477640 |
0.9873 | High Similarity | NPC225597 |
0.9873 | High Similarity | NPC470739 |
0.9872 | High Similarity | NPC58766 |
0.9872 | High Similarity | NPC475686 |
0.9809 | High Similarity | NPC474475 |
0.9688 | High Similarity | NPC474470 |
0.9568 | High Similarity | NPC244554 |
0.9487 | High Similarity | NPC215829 |
0.9487 | High Similarity | NPC97072 |
0.9434 | High Similarity | NPC100566 |
0.9367 | High Similarity | NPC218614 |
0.9367 | High Similarity | NPC320104 |
0.9355 | High Similarity | NPC78733 |
0.9317 | High Similarity | NPC311991 |
0.9313 | High Similarity | NPC181653 |
0.9313 | High Similarity | NPC190332 |
0.9313 | High Similarity | NPC252960 |
0.9308 | High Similarity | NPC247972 |
0.9198 | High Similarity | NPC75958 |
0.9146 | High Similarity | NPC304675 |
0.9091 | High Similarity | NPC237044 |
0.9085 | High Similarity | NPC2314 |
0.9036 | High Similarity | NPC474325 |
0.9036 | High Similarity | NPC15919 |
0.9012 | High Similarity | NPC476002 |
0.8982 | High Similarity | NPC474745 |
0.8957 | High Similarity | NPC57812 |
0.8957 | High Similarity | NPC474324 |
0.8938 | High Similarity | NPC59028 |
0.8938 | High Similarity | NPC92191 |
0.8931 | High Similarity | NPC147091 |
0.8922 | High Similarity | NPC294790 |
0.8922 | High Similarity | NPC118633 |
0.8922 | High Similarity | NPC148693 |
0.8909 | High Similarity | NPC65403 |
0.8902 | High Similarity | NPC475845 |
0.8861 | High Similarity | NPC148898 |
0.8848 | High Similarity | NPC474708 |
0.8824 | High Similarity | NPC474746 |
0.8824 | High Similarity | NPC475981 |
0.8802 | High Similarity | NPC187678 |
0.8772 | High Similarity | NPC9867 |
0.8765 | High Similarity | NPC205167 |
0.8765 | High Similarity | NPC4304 |
0.8765 | High Similarity | NPC249274 |
0.8726 | High Similarity | NPC475959 |
0.8721 | High Similarity | NPC230098 |
0.869 | High Similarity | NPC49353 |
0.8655 | High Similarity | NPC248642 |
0.8647 | High Similarity | NPC126284 |
0.8625 | High Similarity | NPC233029 |
0.8625 | High Similarity | NPC223124 |
0.8625 | High Similarity | NPC210148 |
0.8616 | High Similarity | NPC274026 |
0.8614 | High Similarity | NPC150879 |
0.8605 | High Similarity | NPC156576 |
0.858 | High Similarity | NPC234392 |
0.858 | High Similarity | NPC31311 |
0.8547 | High Similarity | NPC275132 |
0.8519 | High Similarity | NPC41178 |
0.8519 | High Similarity | NPC138487 |
0.8519 | High Similarity | NPC216459 |
0.85 | High Similarity | NPC223125 |
0.8494 | Intermediate Similarity | NPC276944 |
0.8494 | Intermediate Similarity | NPC231198 |
0.8494 | Intermediate Similarity | NPC238530 |
0.8494 | Intermediate Similarity | NPC232514 |
0.8476 | Intermediate Similarity | NPC111485 |
0.8466 | Intermediate Similarity | NPC146288 |
0.8439 | Intermediate Similarity | NPC102760 |
0.8439 | Intermediate Similarity | NPC233718 |
0.8434 | Intermediate Similarity | NPC233650 |
0.843 | Intermediate Similarity | NPC99179 |
0.8418 | Intermediate Similarity | NPC130926 |
0.84 | Intermediate Similarity | NPC214116 |
0.8395 | Intermediate Similarity | NPC82285 |
0.8395 | Intermediate Similarity | NPC133011 |
0.8393 | Intermediate Similarity | NPC210918 |
0.8383 | Intermediate Similarity | NPC134858 |
0.8364 | Intermediate Similarity | NPC477080 |
0.8333 | Intermediate Similarity | NPC24264 |
0.8333 | Intermediate Similarity | NPC476432 |
0.8323 | Intermediate Similarity | NPC59567 |
0.8313 | Intermediate Similarity | NPC165797 |
0.8303 | Intermediate Similarity | NPC315707 |
0.8303 | Intermediate Similarity | NPC78359 |
0.8303 | Intermediate Similarity | NPC65490 |
0.8303 | Intermediate Similarity | NPC148014 |
0.8303 | Intermediate Similarity | NPC40389 |
0.8302 | Intermediate Similarity | NPC185838 |
0.8284 | Intermediate Similarity | NPC247389 |
0.8284 | Intermediate Similarity | NPC210140 |
0.828 | Intermediate Similarity | NPC474915 |
0.828 | Intermediate Similarity | NPC328750 |
0.828 | Intermediate Similarity | NPC213206 |
0.828 | Intermediate Similarity | NPC188163 |
0.8274 | Intermediate Similarity | NPC16805 |
0.8274 | Intermediate Similarity | NPC167546 |
0.8274 | Intermediate Similarity | NPC225774 |
0.8274 | Intermediate Similarity | NPC180306 |
0.8274 | Intermediate Similarity | NPC302527 |
0.8266 | Intermediate Similarity | NPC320223 |
0.8266 | Intermediate Similarity | NPC114364 |
0.8261 | Intermediate Similarity | NPC147390 |
0.8261 | Intermediate Similarity | NPC135538 |
0.8261 | Intermediate Similarity | NPC24233 |
0.8261 | Intermediate Similarity | NPC476571 |
0.8261 | Intermediate Similarity | NPC246587 |
0.8261 | Intermediate Similarity | NPC428 |
0.8258 | Intermediate Similarity | NPC7018 |
0.8256 | Intermediate Similarity | NPC128560 |
0.8256 | Intermediate Similarity | NPC229166 |
0.8256 | Intermediate Similarity | NPC199465 |
0.8246 | Intermediate Similarity | NPC57272 |
0.8242 | Intermediate Similarity | NPC323443 |
0.8242 | Intermediate Similarity | NPC180756 |
0.8235 | Intermediate Similarity | NPC160570 |
0.8229 | Intermediate Similarity | NPC476575 |
0.8225 | Intermediate Similarity | NPC124657 |
0.8225 | Intermediate Similarity | NPC219341 |
0.8217 | Intermediate Similarity | NPC314682 |
0.8199 | Intermediate Similarity | NPC179825 |
0.8199 | Intermediate Similarity | NPC191376 |
0.8199 | Intermediate Similarity | NPC321505 |
0.8199 | Intermediate Similarity | NPC476151 |
0.8193 | Intermediate Similarity | NPC129603 |
0.8182 | Intermediate Similarity | NPC76079 |
0.8182 | Intermediate Similarity | NPC93593 |
0.8176 | Intermediate Similarity | NPC301189 |
0.8176 | Intermediate Similarity | NPC298186 |
0.8176 | Intermediate Similarity | NPC298979 |
0.8166 | Intermediate Similarity | NPC169743 |
0.8156 | Intermediate Similarity | NPC63152 |
0.8148 | Intermediate Similarity | NPC37144 |
0.8148 | Intermediate Similarity | NPC59907 |
0.8146 | Intermediate Similarity | NPC141440 |
0.8144 | Intermediate Similarity | NPC106786 |
0.8133 | Intermediate Similarity | NPC37205 |
0.8133 | Intermediate Similarity | NPC160931 |
0.8114 | Intermediate Similarity | NPC267408 |
0.8111 | Intermediate Similarity | NPC117717 |
0.8103 | Intermediate Similarity | NPC283999 |
0.8098 | Intermediate Similarity | NPC103379 |
0.8098 | Intermediate Similarity | NPC477565 |
0.8095 | Intermediate Similarity | NPC18402 |
0.8095 | Intermediate Similarity | NPC477559 |
0.8095 | Intermediate Similarity | NPC306902 |
0.8095 | Intermediate Similarity | NPC266753 |
0.8095 | Intermediate Similarity | NPC160298 |
0.8095 | Intermediate Similarity | NPC232924 |
0.8086 | Intermediate Similarity | NPC210437 |
0.8086 | Intermediate Similarity | NPC106295 |
0.8086 | Intermediate Similarity | NPC16107 |
0.8086 | Intermediate Similarity | NPC476144 |
0.8086 | Intermediate Similarity | NPC51957 |
0.8084 | Intermediate Similarity | NPC475326 |
0.8081 | Intermediate Similarity | NPC329911 |
0.8072 | Intermediate Similarity | NPC127674 |
0.8072 | Intermediate Similarity | NPC295691 |
0.8072 | Intermediate Similarity | NPC184026 |
0.8072 | Intermediate Similarity | NPC54379 |
0.8072 | Intermediate Similarity | NPC278799 |
0.8072 | Intermediate Similarity | NPC2413 |
0.8072 | Intermediate Similarity | NPC207757 |
0.8072 | Intermediate Similarity | NPC39701 |
0.8072 | Intermediate Similarity | NPC276588 |
0.8072 | Intermediate Similarity | NPC193949 |
0.8072 | Intermediate Similarity | NPC189266 |
0.8072 | Intermediate Similarity | NPC110416 |
0.8072 | Intermediate Similarity | NPC204828 |
0.8072 | Intermediate Similarity | NPC469817 |
0.8072 | Intermediate Similarity | NPC5238 |
0.8072 | Intermediate Similarity | NPC249797 |
0.8072 | Intermediate Similarity | NPC172765 |
0.8063 | Intermediate Similarity | NPC128019 |
0.8063 | Intermediate Similarity | NPC136860 |
0.8063 | Intermediate Similarity | NPC476567 |
0.8059 | Intermediate Similarity | NPC76116 |
0.8049 | Intermediate Similarity | NPC192768 |
0.8049 | Intermediate Similarity | NPC220858 |
0.8049 | Intermediate Similarity | NPC97221 |
0.8049 | Intermediate Similarity | NPC88249 |
0.8049 | Intermediate Similarity | NPC151895 |
0.8045 | Intermediate Similarity | NPC237579 |
0.8037 | Intermediate Similarity | NPC7467 |
0.8036 | Intermediate Similarity | NPC69360 |
0.8035 | Intermediate Similarity | NPC149090 |
0.8035 | Intermediate Similarity | NPC19520 |
0.8023 | Intermediate Similarity | NPC116284 |
0.8022 | Intermediate Similarity | NPC33256 |
0.8012 | Intermediate Similarity | NPC13916 |
0.8012 | Intermediate Similarity | NPC264850 |
0.8 | Intermediate Similarity | NPC124433 |
0.8 | Intermediate Similarity | NPC241704 |
0.8 | Intermediate Similarity | NPC293871 |
0.7988 | Intermediate Similarity | NPC207824 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC266176 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8333 | Intermediate Similarity | NPD6071 | Discontinued |
0.8303 | Intermediate Similarity | NPD2560 | Approved |
0.8303 | Intermediate Similarity | NPD2563 | Approved |
0.828 | Intermediate Similarity | NPD4664 | Clinical (unspecified phase) |
0.8232 | Intermediate Similarity | NPD4773 | Phase 2 |
0.8232 | Intermediate Similarity | NPD4772 | Phase 2 |
0.8176 | Intermediate Similarity | NPD2969 | Approved |
0.8176 | Intermediate Similarity | NPD2970 | Approved |
0.8133 | Intermediate Similarity | NPD6818 | Clinical (unspecified phase) |
0.8118 | Intermediate Similarity | NPD3051 | Approved |
0.8113 | Intermediate Similarity | NPD4236 | Phase 3 |
0.8113 | Intermediate Similarity | NPD4237 | Approved |
0.8086 | Intermediate Similarity | NPD4584 | Approved |
0.8024 | Intermediate Similarity | NPD2978 | Approved |
0.8024 | Intermediate Similarity | NPD2977 | Approved |
0.8023 | Intermediate Similarity | NPD2489 | Approved |
0.8023 | Intermediate Similarity | NPD27 | Approved |
0.8012 | Intermediate Similarity | NPD5241 | Discontinued |
0.7963 | Intermediate Similarity | NPD6783 | Clinical (unspecified phase) |
0.7935 | Intermediate Similarity | NPD4420 | Approved |
0.7923 | Intermediate Similarity | NPD5582 | Discontinued |
0.7919 | Intermediate Similarity | NPD4481 | Phase 3 |
0.7901 | Intermediate Similarity | NPD5084 | Clinical (unspecified phase) |
0.7861 | Intermediate Similarity | NPD5006 | Approved |
0.7861 | Intermediate Similarity | NPD5005 | Approved |
0.7816 | Intermediate Similarity | NPD2898 | Approved |
0.7811 | Intermediate Similarity | NPD5772 | Approved |
0.7811 | Intermediate Similarity | NPD5773 | Approved |
0.7791 | Intermediate Similarity | NPD7201 | Clinical (unspecified phase) |
0.779 | Intermediate Similarity | NPD7906 | Approved |
0.7765 | Intermediate Similarity | NPD7280 | Phase 3 |
0.7765 | Intermediate Similarity | NPD7281 | Phase 3 |
0.7746 | Intermediate Similarity | NPD6107 | Approved |
0.7735 | Intermediate Similarity | NPD4663 | Approved |
0.7725 | Intermediate Similarity | NPD4210 | Discontinued |
0.7679 | Intermediate Similarity | NPD4017 | Approved |
0.7667 | Intermediate Similarity | NPD4578 | Approved |
0.7667 | Intermediate Similarity | NPD7312 | Approved |
0.7667 | Intermediate Similarity | NPD7310 | Approved |
0.7667 | Intermediate Similarity | NPD7313 | Approved |
0.7667 | Intermediate Similarity | NPD7311 | Approved |
0.7667 | Intermediate Similarity | NPD4577 | Approved |
0.7665 | Intermediate Similarity | NPD3639 | Approved |
0.7665 | Intermediate Similarity | NPD3641 | Approved |
0.7665 | Intermediate Similarity | NPD3640 | Phase 3 |
0.7624 | Intermediate Similarity | NPD7309 | Approved |
0.7596 | Intermediate Similarity | NPD7243 | Clinical (unspecified phase) |
0.7584 | Intermediate Similarity | NPD8156 | Discontinued |
0.7572 | Intermediate Similarity | NPD7832 | Clinical (unspecified phase) |
0.7572 | Intermediate Similarity | NPD7833 | Phase 2 |
0.7572 | Intermediate Similarity | NPD7831 | Phase 2 |
0.7568 | Intermediate Similarity | NPD7296 | Approved |
0.7561 | Intermediate Similarity | NPD3060 | Approved |
0.756 | Intermediate Similarity | NPD6031 | Approved |
0.756 | Intermediate Similarity | NPD6030 | Approved |
0.7545 | Intermediate Similarity | NPD1754 | Clinical (unspecified phase) |
0.7544 | Intermediate Similarity | NPD7298 | Approved |
0.7532 | Intermediate Similarity | NPD2669 | Clinical (unspecified phase) |
0.7528 | Intermediate Similarity | NPD8099 | Discontinued |
0.7528 | Intermediate Similarity | NPD8252 | Approved |
0.7528 | Intermediate Similarity | NPD8251 | Approved |
0.7527 | Intermediate Similarity | NPD8054 | Approved |
0.7527 | Intermediate Similarity | NPD8053 | Approved |
0.75 | Intermediate Similarity | NPD4010 | Discontinued |
0.75 | Intermediate Similarity | NPD6297 | Approved |
0.7471 | Intermediate Similarity | NPD5604 | Discontinued |
0.747 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7447 | Intermediate Similarity | NPD7667 | Clinical (unspecified phase) |
0.7438 | Intermediate Similarity | NPD554 | Clinical (unspecified phase) |
0.7432 | Intermediate Similarity | NPD6851 | Approved |
0.7432 | Intermediate Similarity | NPD6853 | Approved |
0.7414 | Intermediate Similarity | NPD6788 | Approved |
0.7407 | Intermediate Similarity | NPD2974 | Approved |
0.7407 | Intermediate Similarity | NPD2975 | Approved |
0.7407 | Intermediate Similarity | NPD2973 | Approved |
0.7401 | Intermediate Similarity | NPD4166 | Phase 2 |
0.7389 | Intermediate Similarity | NPD5313 | Approved |
0.7389 | Intermediate Similarity | NPD5312 | Approved |
0.7368 | Intermediate Similarity | NPD4005 | Discontinued |
0.7349 | Intermediate Similarity | NPD4162 | Approved |
0.7333 | Intermediate Similarity | NPD1375 | Discontinued |
0.731 | Intermediate Similarity | NPD3686 | Approved |
0.731 | Intermediate Similarity | NPD3687 | Approved |
0.7292 | Intermediate Similarity | NPD4580 | Approved |
0.7283 | Intermediate Similarity | NPD2971 | Approved |
0.7283 | Intermediate Similarity | NPD2968 | Approved |
0.7267 | Intermediate Similarity | NPD5718 | Phase 2 |
0.7263 | Intermediate Similarity | NPD6687 | Approved |
0.7263 | Intermediate Similarity | NPD6688 | Approved |
0.7256 | Intermediate Similarity | NPD6895 | Approved |
0.7256 | Intermediate Similarity | NPD6896 | Approved |
0.7254 | Intermediate Similarity | NPD2494 | Approved |
0.7254 | Intermediate Similarity | NPD3450 | Approved |
0.7254 | Intermediate Similarity | NPD3452 | Approved |
0.7254 | Intermediate Similarity | NPD2493 | Approved |
0.7251 | Intermediate Similarity | NPD4727 | Phase 1 |
0.7246 | Intermediate Similarity | NPD5177 | Phase 3 |
0.7243 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7235 | Intermediate Similarity | NPD1424 | Approved |
0.7235 | Intermediate Similarity | NPD4123 | Phase 3 |
0.7234 | Intermediate Similarity | NPD2488 | Approved |
0.7234 | Intermediate Similarity | NPD2490 | Approved |
0.7234 | Intermediate Similarity | NPD5525 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD6365 | Clinical (unspecified phase) |
0.7219 | Intermediate Similarity | NPD7124 | Phase 2 |
0.7212 | Intermediate Similarity | NPD6028 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD6029 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD1753 | Discontinued |
0.7195 | Intermediate Similarity | NPD2492 | Phase 1 |
0.7178 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7176 | Intermediate Similarity | NPD3124 | Discontinued |
0.7175 | Intermediate Similarity | NPD7975 | Clinical (unspecified phase) |
0.7174 | Intermediate Similarity | NPD7149 | Clinical (unspecified phase) |
0.7168 | Intermediate Similarity | NPD7261 | Clinical (unspecified phase) |
0.716 | Intermediate Similarity | NPD2677 | Approved |
0.7151 | Intermediate Similarity | NPD5976 | Discontinued |
0.715 | Intermediate Similarity | NPD7827 | Phase 1 |
0.7143 | Intermediate Similarity | NPD3808 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD5752 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD4582 | Approved |
0.7143 | Intermediate Similarity | NPD4583 | Approved |
0.7143 | Intermediate Similarity | NPD7945 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD3705 | Approved |
0.7119 | Intermediate Similarity | NPD4581 | Clinical (unspecified phase) |
0.7095 | Intermediate Similarity | NPD5677 | Discontinued |
0.7093 | Intermediate Similarity | NPD7527 | Clinical (unspecified phase) |
0.7093 | Intermediate Similarity | NPD7526 | Approved |
0.7093 | Intermediate Similarity | NPD52 | Approved |
0.7092 | Intermediate Similarity | NPD4002 | Approved |
0.7092 | Intermediate Similarity | NPD4004 | Approved |
0.7091 | Intermediate Similarity | NPD817 | Approved |
0.7091 | Intermediate Similarity | NPD823 | Approved |
0.7088 | Intermediate Similarity | NPD5602 | Clinical (unspecified phase) |
0.7087 | Intermediate Similarity | NPD6997 | Phase 2 |
0.7083 | Intermediate Similarity | NPD1372 | Clinical (unspecified phase) |
0.7079 | Intermediate Similarity | NPD4055 | Discovery |
0.7073 | Intermediate Similarity | NPD3109 | Approved |
0.7073 | Intermediate Similarity | NPD3110 | Approved |
0.7066 | Intermediate Similarity | NPD2161 | Phase 2 |
0.7065 | Intermediate Similarity | NPD3885 | Approved |
0.7063 | Intermediate Similarity | NPD4104 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD4103 | Phase 2 |
0.7062 | Intermediate Similarity | NPD7237 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD3692 | Discontinued |
0.7056 | Intermediate Similarity | NPD7802 | Discontinued |
0.7051 | Intermediate Similarity | NPD1357 | Approved |
0.7044 | Intermediate Similarity | NPD7047 | Phase 3 |
0.7041 | Intermediate Similarity | NPD3057 | Approved |
0.7029 | Intermediate Similarity | NPD4675 | Approved |
0.7029 | Intermediate Similarity | NPD4678 | Approved |
0.702 | Intermediate Similarity | NPD7607 | Clinical (unspecified phase) |
0.7012 | Intermediate Similarity | NPD2674 | Phase 3 |
0.7005 | Intermediate Similarity | NPD3534 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD2041 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD7235 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD2042 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD2421 | Approved |
0.6977 | Remote Similarity | NPD2420 | Approved |
0.6977 | Remote Similarity | NPD1774 | Approved |
0.6966 | Remote Similarity | NPD5977 | Approved |
0.6966 | Remote Similarity | NPD5978 | Approved |
0.6959 | Remote Similarity | NPD5160 | Discontinued |
0.6954 | Remote Similarity | NPD2972 | Approved |
0.6954 | Remote Similarity | NPD3533 | Approved |
0.6954 | Remote Similarity | NPD2122 | Discontinued |
0.6952 | Remote Similarity | NPD7132 | Clinical (unspecified phase) |
0.6949 | Remote Similarity | NPD3383 | Approved |
0.6949 | Remote Similarity | NPD3384 | Approved |
0.6949 | Remote Similarity | NPD3382 | Approved |
0.6946 | Remote Similarity | NPD6111 | Discontinued |
0.6944 | Remote Similarity | NPD7400 | Phase 3 |
0.6944 | Remote Similarity | NPD5709 | Phase 3 |
0.6939 | Remote Similarity | NPD4107 | Approved |
0.6937 | Remote Similarity | NPD4659 | Approved |
0.6936 | Remote Similarity | NPD2874 | Phase 2 |
0.6936 | Remote Similarity | NPD7020 | Approved |
0.6936 | Remote Similarity | NPD7019 | Approved |
0.6936 | Remote Similarity | NPD4739 | Approved |
0.6935 | Remote Similarity | NPD7007 | Discovery |
0.6931 | Remote Similarity | NPD5676 | Approved |
0.6923 | Remote Similarity | NPD3656 | Approved |
0.6919 | Remote Similarity | NPD3845 | Phase 1 |
0.6919 | Remote Similarity | NPD3122 | Phase 3 |
0.6909 | Remote Similarity | NPD1130 | Approved |
0.6909 | Remote Similarity | NPD4474 | Approved |
0.6909 | Remote Similarity | NPD1136 | Approved |
0.6909 | Remote Similarity | NPD1132 | Approved |
0.6909 | Remote Similarity | NPD4475 | Approved |
0.6906 | Remote Similarity | NPD2904 | Discontinued |
0.6906 | Remote Similarity | NPD4666 | Phase 3 |
0.6905 | Remote Similarity | NPD4108 | Discontinued |
0.6901 | Remote Similarity | NPD6658 | Clinical (unspecified phase) |
0.6901 | Remote Similarity | NPD6331 | Phase 2 |
0.6899 | Remote Similarity | NPD2668 | Approved |
0.6899 | Remote Similarity | NPD2667 | Approved |
0.6897 | Remote Similarity | NPD6090 | Discontinued |
0.6895 | Remote Similarity | NPD3857 | Clinical (unspecified phase) |
0.6893 | Remote Similarity | NPD6072 | Discontinued |
0.689 | Remote Similarity | NPD3179 | Approved |
0.689 | Remote Similarity | NPD3180 | Approved |
PubChem CID   | 441593 |
ChEMBL   | CHEMBL401114 |
ZINC   |
Molecular Weight:   | 301.13 |
ALogP:   | -1.1196 |
MLogP:   | 2.78 |
XLogP:   | 0.478 |
# Rotatable Bonds:   | 3 |
Polar Surface Area:   | 51.16 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 1 |
# Rings:   | 5 |
# Heavy Atoms:   | 22 |